Search
for
Sort by
Research 91–120 of 1000+
- Are bald men more virile than their well thatched contemporaries?
- Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7
- Adverse Side Effects of 5α‐Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients
- Age-Related Differences for Male-to-Female Transgender Patients Undergoing Gender-Affirming Surgery
- Testosterone Treatment in Women – An Overview
- The role of androgens in hormone replacement therapy
- Sexual Dysfunction in Alopecia Areata: A Systematic Review
- Clinical Evaluation of Women Presenting with Low Libido and Determination of Whether Androgen Therapy Might Be Appropriate
- POST-FINASTERIDE SYNDROME AND POST-SSRI SEXUAL DYSFUNCTION: TWO CLINICAL CONDITIONS APPARENTLY DISTANT, BUT VERY CLOSE
- Finasteride inhibits epinephrine synthesis in humans: implication for sexual dysfunction
- Sexual Dysfunction in Polycystic Ovary Syndrome (PCOS): A Biopsychosocial Approach to Assessment and Management
- Association of hirsutism and anthropometric profiles with sexual dysfunction and anxiety levels in infertile Indonesian women with polycystic ovarian syndrome
- Investigation of the Plausibility of 5-Alpha-Reductase Inhibitor Syndrome
- Deciphering principles of morphogenesis from temporal and spatial patterns on the integument
- Post-Finasteride Syndrome: An Induced Delusional Disorder with the Potential of a Mass Psychogenic Illness?
- New lifestyle drugs and somatoform disorders in dermatology
- Nocebo effect in Dermatology
- Polycystic ovarian syndrome elevates the distress of sexual pain in Iranian women with infertility
- A Child with Nonscarring Alopecia
- Effects of 5-alpha reductase inhibitors
- Finasteride withdrawal induces anxiety-like behavior and novelty avoidance in adult male rats.
- Multidimensional assessment of adverse events of finasteride：a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
- The therapeutic use of androgens in women
- Efficacy and Safety of Finasteride Therapy for Androgenetic Alopecia
- The rationale for physiological testosterone replacement in women
- 5-alpha reductase inhibitors: New evidences on benefits and harms beyond benign prostatic hyperplasia
- Changes of androgens levels in menopausal women
- International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women
- International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women
- Behavioral Welfare Research for the Management of Sanctuary Chimpanzees (Pan troglodytes)